Autres langues Becton, Dickinson and Company

Actions

BDX

US0758871091

Equipement, fournitures et distribution médicale

Temps réel estimé Cboe BZX 18:22:47 24/08/2026			Varia. 5j.	Varia. 1 janv.
191,65 ^USD	-0,18%		+5,22%	-1,27%

17/08	Becton, Dickinson and Company annonce la nomination de Gary Sorsher au poste de vice-président exécutif et directeur de la qualité, à compter du 8 septembre 2026	CI
17/08	Becton Dickinson nomme Gary Sorsher au poste de Chief Quality Officer	MT

Autres langues

17/08	Becton, Dickinson and Company Announces Management Changes
17/08	Becton Dickinson Names Gary Sorsher as Chief Quality Officer
17/08	BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire
17/08	Jeffrey Silvestri to Retire as Senior Vice President, Global Head of Quality of Becton, Dickinson and Company in October 2026
13/08	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says
12/08	Becton Dickinson & Co Insider Sold Shares Worth $440,888, According to a Recent SEC Filing
12/08	Becton, Dickinson Completes Enrollment in Trial for Phasix Mesh
12/08	BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial
12/08	Becton, Dickinson And Company Completes Enrollment In The PREVENT Clinical Trial Evaluating Phasix Mesh For Incisional Hernia Prevention
07/08	Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says
06/08	Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 28, 2025.
06/08	Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 27, 2026.
06/08	Becton Dickinson Lifts Full-Year Profit Outlook as Third-Quarter Results Top Views
06/08	Becton, Dickinson and Company Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2026
06/08	Becton, Dickinson and Company Updates Revenue Growth Guidance for the Full Year Fiscal 2026
06/08	Stocks Mostly Up Pre-Bell as Investors Weigh Potential Iran-Oman Hormuz Deal, Await More Earnings
06/08	Becton, Dickinson Fiscal Q3 Adjusted Earnings, Revenue Rise; Lifts 2026 Adjusted EPS Guidance
06/08	Becton Dickinson raises lower end of annual profit forecast on drug delivery devices strength
06/08	(BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.62 to $12.72,vs. FactSet Est of $12.61
06/08	Becton Dickinson: Fiscal Q3 Earnings Snapshot
06/08	Earnings Flash (BDX) Becton, Dickinson and Company Reports Q3 Revenue $4.98B
06/08	Earnings Flash (BDX) Becton, Dickinson and Company Posts Q3 Adjusted EPS $3.23 per Share
06/08	BD Reports Third Quarter Fiscal 2026 Financial Results
04/08	Waters lifts annual forecasts on strong lab-equipment and diagnostics demand
31/07	Becton Dickinson issues recall on certain lots of needle sets used for emergency IV access